⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SEPN News
Septerna, Inc. Common Stock
Septerna to Present at TD Cowen 46th Annual Health Care Conference
globenewswire.com
SEPN
Septerna Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
SEPN
Septerna to Present Data from Phase 1 Clinical Trial of SEP-631 for the Treatment of Mast Cell-Driven Diseases at 2026 AAAAI Annual Meeting
globenewswire.com
SEPN
Septerna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal Officer
globenewswire.com
SEPN
Septerna to Present at 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
SEPN
Septerna to Participate in 8th Annual Evercore Healthcare Conference
globenewswire.com
SEPN
Septerna Highlights Company Progress and Reports Third Quarter 2025 Financial Results
globenewswire.com
SEPN
Septerna to Participate in Upcoming Investor Conferences
globenewswire.com
SEPN
Septerna Appoints Veteran Biotechnology Leader Keith Gottesdiener, M.D., to its Board of Directors
globenewswire.com
SEPN